English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Thursday, April 25, 2024
Press Releases for Friday, January 4, 2019
Six Young Hong Kong Fashion Labels in Focus
18:00 HKT/SGT
Asia's Largest Toys & Games Fair Opens Next Week
15:00 HKT/SGT
ISID、電通グループの「個人データ銀行」事業会社に出資
14:00 HKT/SGT
腾讯概念股微盟公开发售 富途证券新股承销再下一城
12:36 HKT/SGT
騰訊概念股微盟公開發售 富途證券新股承銷再下一城
12:35 HKT/SGT
新零售时代中小企业最佳服务商 微盟集团招股引热议
12:25 HKT/SGT
新零售時代中小企業最佳服務商 微盟集團招股引熱議
12:24 HKT/SGT
三大基石——上海双创、丙晟科技、汇付天下(1806.HK)入股 微盟集团招股进行时
12:08 HKT/SGT
三大基石——上海雙創、丙晟科技、匯付天下(1806.HK)入股 微盟集團招股進行時
12:06 HKT/SGT
エーザイ、抗てんかん剤ペランパネルが中国当局より部分てんかん併用療法に係る適応の新薬承認申請について優先審査に指定
12:00 HKT/SGT
SaaS+PaaS+精准营销 共筑业绩高涨 具强大投资阵容的微盟现正招股
11:55 HKT/SGT
SaaS+PaaS+精准營銷 共築業績高漲 具強大投資陣容的微盟現正招股
11:54 HKT/SGT
昭和電工、2019年社長年頭挨拶(要旨)
11:30 HKT/SGT
Eisai's Etak Antimicrobial Spray Alpha Wins Nikkei Business Daily Awards for Superiority at the 2018 Nikkei Superior Products and Services Awards
11:18 HKT/SGT
New Year Message from Kohei Morikawa, Showa Denko President and CEO
10:30 HKT/SGT
AOBiome Therapeutics使用氨氧化细菌(AOB)治疗湿疹获美国专利,扩大知识产权库
09:00 HKT/SGT
AOBiome Therapeutics使用氨氧化細菌(AOB)治療濕疹獲美國專利,擴大知識產權庫
08:57 HKT/SGT
Eisai's New Drug Application for Perampanel Designated for Priority Review by China National Medical Products Administration
08:39 HKT/SGT
Toyota Research Institute Rolls-out P4 Automated Driving Test Vehicle at CES
08:07 HKT/SGT
米Toyota Research Institute, Inc.(TRI)、新型自動運転実験車「TRI-P4」をCES(R)で公開
07:00 HKT/SGT
ACN Search:
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Cookies Policy
|
Privacy Policy
|
Disclaimer
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575